Research for a life without cancer
At the DKFZ, we want to ensure that fewer people develop cancer, that cancer can be cured or treated so effectively that those affected can live with the disease and grow old with a good quality of life.
About DKFZ 
Latest from DKFZ
The 2023/24 Meyenburg Prize, endowed with 50,000 euros, goes to Michel Sadelain of Columbia University, New York. The physician and immunologist is considered one of the fathers of CAR-T cell therapy. This cellular immunotherapy can be used to effectively treat certain blood cancers, even in advanced stages. The Meyenburg Prize will be awarded on Wednesday, April 2, at a festive symposium* at the German Cancer Research Center (DKFZ).
Our research opens doors in the fight against cancer
Do you have questions on the topic of cancer?
Let us advise you!
Doctors from the German Cancer Information Service answer your questions every day. Find out more now for free!
0800 - 420 30 40 daily from 8 a.m. to 8 p.m.
